PsyTech VR Showcases Transformative VR Therapy at ACBS World Conference 2025
PsyTech VR demonstrated how VR exposure therapy can revolutionize treatment for anxiety, phobias, OCD, PTSD, and more at the ACBS World Conference 2025, highlighting its potential to make evidence-based mental health care more accessible and effective.
PsyTech VR took center stage at the ACBS World Conference 2025, showcasing the transformative potential of VR exposure therapy for treating a range of mental health conditions, including anxiety, phobias, OCD, and PTSD. Represented by advisory board members Dr. Gwilym Roddick and Dr. Melanie Smith, the company engaged with clinicians on how VR technology can enhance cognitive behavioral therapy (CBT) by creating immersive, personalized environments for exposure therapy.
At their booth, attendees had the opportunity to explore PsyTech VR's platform, experiencing firsthand how it supports clinical use cases such as phobias, stress disorders, and addiction management. The platform, developed with science-backed protocols, aims to simplify the integration of VR into mental health practices, offering a clinically sound tool for therapists.
The enthusiasm from conference attendees underscored the growing interest in VR as a tool for mental health treatment. Dr. Roddick noted the eagerness of clinicians to adopt this technology, emphasizing its ability to extend the boundaries of traditional therapy into more structured and immersive experiences. PsyTech VR's presentation at ACBS 2025 highlighted the company's role in advancing evidence-based mental health care through innovative technology.